CF
TEVA icon

Cantor Fitzgerald’s Teva Pharmaceuticals TEVA Stock Holding History

Cantor Fitzgerald’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68,890
Closed -$1.39M – 364
2025
Q3 		$1.39M Buy
+68,890
New +$1.21M 0.01% 187
2025
Q2 		– Sell
-51,100
Closed -$785K – 532
2025
Q1 		$785K Buy
+51,100
New +$913K 0.02% 126
2023
Q1 		– Sell
-10,352
Closed -$94K – 728
2022
Q4 		$94K Buy
+10,352
New +$90.3K ﹤0.01% 609
2022
Q1 		– Sell
-11,066
Closed -$89K – 436
2021
Q4 		$89K Buy
+11,066
New +$99.9K 0.01% 317

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Cantor Fitzgerald's TEVA Position: Q4 2025 in Review

Cantor Fitzgerald sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 68,890 shares — an estimated $1.39M sold.

Cantor Fitzgerald first reported a position in TEVA in Q4 2021 and held it in 4 quarters. The position peaked at $1.39M in Q3 2025. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • Cantor Fitzgerald reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 68,890 Teva Pharmaceuticals shares in Q4 2025, an estimated $1.39M.
  • Cantor Fitzgerald first reported a position in Teva Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Cantor Fitzgerald's Teva Pharmaceuticals position peaked at $1.39M in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on Cantor Fitzgerald's 13F filing for Q4 2025, filed 17 Feb 2026.